genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics. The Preclinical Research Services division provides pre-clinical testing services in the areas of oncology, oncology supportive care, inflammatory bowel disease, leukaemia, gastrointestinal disease, inflammation, skin care and wound healing, and rheumatoid arthritis. The Pharmacogenomic Services division offers molecular measures of biological processes. The Diagnostics division is involved in commercializing the Genedrive point of need molecular testing platform. It serves biotechnology and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is based in Manchester, the United Kingdom.
Industry, Sector and Symbol
Stock Exchange LON
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolLON:GDR
Previous SymbolLON:EHP
CUSIPN/A
Phone+44-161-9890245
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees79
Outstanding SharesN/A
Market Cap£0.00
OptionableNot Optionable
Genedrive (LON:GDR) Frequently Asked Questions
What is Genedrive's stock symbol?
Genedrive trades on the London Stock Exchange (LON) under the ticker symbol "GDR."
How were Genedrive's earnings last quarter?
Genedrive PLC (LON:GDR) posted its earnings results on Tuesday, March, 20th. The company reported ($9.00) earnings per share for the quarter. The business had revenue of $2.63 million for the quarter. View Genedrive's Earnings History.
What price target have analysts set for GDR?
1 equities research analysts have issued 12 month target prices for Genedrive's shares. Their forecasts range from GBX 152 to GBX 152. On average, they expect Genedrive's stock price to reach GBX 152 in the next year. This suggests a possible upside of 537.6% from the stock's current price. View Analyst Price Targets for Genedrive.
What is the consensus analysts' recommendation for Genedrive?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genedrive in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Genedrive.
Has Genedrive been receiving favorable news coverage?
Media stories about GDR stock have been trending positive this week, according to InfoTrie. The research group scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Genedrive earned a media sentiment score of 2.2 on InfoTrie's scale. They also gave news stories about the company a news buzz of 8.0 out of 10, indicating that recent news coverage is very likely to have an impact on the stock's share price in the next few days.
Who are some of Genedrive's key competitors?
Some companies that are related to Genedrive include 3D Signatures (DXD), BioNano Genomics (BNGOU), Cambridge Cognition (COG), Carl Data Solutions (CRL), Carl Zeiss Meditec (AFX), Co-Diagnostics (CODX), Deepmatter Group (DMTR), EPIGENOMICS AG/S (EPGNY), Eternity Healthcare (ETAH), GeneNews (GEN), Imaging Dynamics (IDL), LED Medical Diagnostics (LMD), Lexagene (LXG), MaxCyte (MXCT) and Med Biogene (MBI).
Who are Genedrive's key executives?
Genedrive's management team includes the folowing people:
- Mr. David Budd, Chief Exec. Officer and Director (Age 50)
- Mr. Matthew J. Fowler, CFO, Company Sec. & Director (Age 43)
How do I buy shares of Genedrive?
Shares of GDR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Genedrive's stock price today?
One share of GDR stock can currently be purchased for approximately GBX 23.84.
What is Genedrive's official website?
How can I contact Genedrive?
Genedrive's mailing address is 48 Grafton Street, MANCHESTER, M13 9XX, United Kingdom. The company can be reached via phone at +44-161-9890245.
MarketBeat Community Rating for Genedrive (LON GDR)
MarketBeat's community ratings are surveys of what our community members think about Genedrive and other stocks. Vote "Outperform" if you believe GDR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GDR will underperform the S&P 500 over the long term. You may vote once every thirty days.
